Abstract:In this work, our primary objective was to examine the interrelationship among the serum level of chemokine (C-C motif) ligand 2 (CCL2) and plaque characteristics in coronary culprit lesions. The clinical data of 116 coronary heart disease patients who were hospitalized in the Department of Cardiology of Henan Province People's Hospital from February 2015 to June 2017 were retrospectively analyzed. The study population was subdivided according to the concentration of CCL2 into low CCL2 group and high CCL2 group. The levels of blood lipid, creatinine, and uric acid were measured, and patients underwent coronary angiography. The characteristics of the culprit lesions were detected by intravascular ultrasound, and the correlation between the serum markers and the characteristics of coronary artery plaque was analyzed. Moreover, the coronary artery disease dataset from the Gene Expression Omnibus database was downloaded and the genes regulated were analyzed by CCL2 using gene set enrichment analysis (GSEA). Patients with high CCL2 group had higher LDL-C level and L/H ratio, and lower HDL-C level than the low CCL2 group. Compared with low-level CCL2 group, coronary plaque in the high CCL2 group had higher eccentric plaque and plaque rupture, and thin cap fibroatheromas, fibrofatty and necrotic core and lower fibrous tissue. CCL2 was positively correlated with the percentage of fibrofatty and necrotic core, and negatively correlated with the percentage of fibrous tissue. Furthermore, GSEA analysis showed that samples with high CCL2 expression were enriched for genes involved in different pathways, such as cell adhesion molecules and Nod-like receptor signaling pathway. The CCL2 level was correlated with vulnerable plaques of coronary artery and had certain value in detecting vulnerable plaques. These results indicated that CCL2 could be regarded as a clinical prognostic biomarker for coronary artery disease. Impact statement Vulnerable plaques are plaques which are susceptible to rupture or thrombosis and trigger a series of adverse events such as coronary disorders. CCL2 is a soluble basic protein belonging to the CC subfamily. Previous studies have been investigated on the correlation between inflammatory factors and clinical events, but there are few studies on the correlation between CCL2 and plaque characteristics. Our study found that the high expression of CCL2 is involved in multiple processes in the genesis and progression of coronary artery disease, and would be a potential clinical prognostic indicator. In addition, high expression of CCL2 may be related to gene pathways such as Nod-like receptor signaling pathway, suggesting that CCL2 is involved in the inflammatory response and immune process of coronary artery disease.

Mannose Binding Lectin and C3 Serum Levels in Coronary Artery Disease: A Cross-Sectional Study

The Relationship Between Soluble Lymphocyte Activation Gene-3 and Coronary Artery Disease

The clinic relevance between acute coronary syndrome and the level of serum matrix metalloproteinase-9

Circulating mannose-binding lectin concentration in patients with stable coronary artery disease is associated with heart failure and renal function

Levels of Soluble Adhesion Molecules in Patients with Various Clinical Presentations of Coronary Atherosclerosis.

Augmented mannose‐binding lectin levels in primary membranous nephropathy: A pilot study

Chemokine CXCL16 Expression in Serum of Patients with Coronary Artery Disease

Correlation Between Monocyte Chemoattractant Protein-1/Chemokine (C-C Motif) Ligand 2 and Coronary Plaque Characteristics.

Application of Serum Protein Fingerprint in Diagnosis of Coronary Artery Disease

The Role Of Mannose-Binding Lectin (Mbl) In Diabetic Retinopathy: A Scoping Review

Changes of Serum Soluble Intercellular Adhesion Molecule-1 and P-selectin in Coronary Heart Disease

Complement Activation Products in the Circulation and Urine of Primary Membranous Nephropathy.

The Role of Mannose-Binding Lectin-Associated Serine Protease-3 in Activation of the Alternative Complement Pathway

Serum IgE levels in coronary artery disease

Expression of Salivary and Serum Malondialdehyde and Lipid Profile of Patients with Periodontitis and Coronary Heart Disease

Serum superoxide dismutase and malondialdehyde as oxidative stress biomarkers in coronary artery disease

Complement Activation in the Arteries of Patients with Severe Atherosclerosis.

The Role of Mannose Binding Lectin in the Pathogenesis of Systemic Lupus Erythematosus

Serum IgE levels are associated with coronary artery disease severity

A Nanoplasmonic Assay for Point-of-Care Detection of Mannose-Binding Lectin in Human Serum

Increased CD14+HLA-DR-/low myeloid-derived suppressor cells can be regarded as a biomarker on disease severity and response to therapy in acute coronary syndrome